Skip to main content
. 2022 May 25;39(7):3308–3315. doi: 10.1007/s12325-022-02179-1

Table 1.

Demographic and clinical characteristics of the study population

Variable Patients with DMD (N = 8)
Age (years) 18.87 ± 6.81
Age at diagnosis (years) 4.75 ± 2.81
BMI (kg/m2) 23.31 ± 5.22
Duration GC therapy (years) 11.5 (2–25)
Functional status
 Ambulant (%) 2 (25%)
 Non-ambulant (%) 6 (75%)
Previous fractures
 Vertebral (%) 1 (12.5%)
 Long-bone (%) 1 (12.5%)

All variables were normally distributed. Continuous variables are expressed as mean ± standard deviation or median (IQR, interquartile range); discrete ones are expressed as total number (%)

DMD Duchenne muscular dystrophy, BMI body mass index, GC glucocorticoid